Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Medical Oncology
•
AYA
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
How do you monitor risk of erythrocytosis from testosterone use for female to male transgender patients?
Related Questions
How would you work up and manage persistent lymphopenia in an asymptomatic patient?
Do you recommend starting an antiplatelet for primary prophylaxis in post splenectomy thrombocytosis given there is some increased risk of venous thrombosis?
Would you consider using DOACs in a young patient with SLE and Libman-Sacks endocarditis, who is negative for APS?
Do you incorporate DVT prophylaxis after joint arthroscopy in a patient with hemophilia?
What are your recommendations for management of patients with familial polycythemia due to EPOR mutation during pregnancy?
How do you advise patients with sickle cell disease on contraception?
At what ferritin threshold would a patient with anemia of inflammation or malignancy no longer benefit from iron supplementation for functional iron deficiency?
Would you recommend adding a TKI to a pediatric regimen for a AYA B-ALL patient with IKZF1 mutation?
How do you mitigate 6-MP-induced GI toxicity in pediatric and AYA patients with leukemia?
What are your recommendations for a male patient who was recently started on imatinib and wants to conceive?